{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T19:17:03Z","timestamp":1771874223473,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12883-014-0246-4","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T19:04:18Z","timestamp":1419015858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Comparison of clinical characteristics between neuromyelitis optica spectrum disorders with and without spinal cord atrophy"],"prefix":"10.1186","volume":"14","author":[{"given":"Yanqiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinyao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,20]]},"reference":[{"issue":"9","key":"246_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG: The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6 (9): 805-815. 10.1016\/S1474-4422(07)70216-8.","journal-title":"Lancet Neurol"},{"key":"246_CR2","first-page":"735486","volume":"2012","author":"W Kim","year":"2012","unstructured":"Kim W, Kim SH, Huh SY, Kim HJ: Brain abnormalities in neuromyelitis optica spectrum disorder. Mult Scler Int. 2012, 2012: 735486-","journal-title":"Mult Scler Int"},{"key":"246_CR3","doi-asserted-by":"crossref","unstructured":"Yang CS, Zhang DQ, Wang JH, Jin WN, Li MS, Liu J, Zhang CJ, Li T, Shi FD, Yang L: Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China. CNS Neurosci Ther 2013.,","DOI":"10.1111\/cns.12156"},{"key":"246_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2377-13-33","volume":"13","author":"N Asgari","year":"2013","unstructured":"Asgari N, Skejoe HP, Lillevang ST, Steenstrup T, Stenager E, Kyvik KO: Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study. BMC Neurol. 2013, 13: 33-10.1186\/1471-2377-13-33.","journal-title":"BMC Neurol"},{"issue":"1\u20132","key":"246_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jns.2010.02.026","volume":"293","author":"Z Lu","year":"2010","unstructured":"Lu Z, Qiu W, Zou Y, Lv K, Long Y, You W, Zheng X, Hu X: Characteristic linear lesions and longitudinally extensive spinal cord lesions in Chinese patients with neuromyelitis optica. J Neurol Sci. 2010, 293 (1\u20132): 92-96. 10.1016\/j.jns.2010.02.026.","journal-title":"J Neurol Sci"},{"key":"246_CR6","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhang L, Zhang B, Dai Y, Kang Z, Lu C, Qiu W, Hu X, Lu Z: Comparative clinical characteristics of neuromyelitis optica spectrum disorders with and without medulla oblongata lesions. J Neurol 2014.,","DOI":"10.1007\/s00415-014-7298-7"},{"issue":"3","key":"246_CR7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1148\/radiol.12120813","volume":"266","author":"P Valsasina","year":"2013","unstructured":"Valsasina P, Rocca MA, Horsfield MA, Absinta M, Messina R, Caputo D, Comi G, Filippi M: Regional cervical cord atrophy and disability in multiple sclerosis: a voxel-based analysis. Radiology. 2013, 266 (3): 853-861. 10.1148\/radiol.12120813.","journal-title":"Radiology"},{"issue":"Pt 3","key":"246_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/brain\/119.3.701","volume":"119","author":"NA Losseff","year":"1996","unstructured":"Losseff NA, Webb SL, O'Riordan JI, Page R, Wang L, Barker GJ, Tofts PS, McDonald WI, Miller DH, Thompson AJ: Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain. 1996, 119 (Pt 3): 701-708. 10.1093\/brain\/119.3.701.","journal-title":"Brain"},{"issue":"2","key":"246_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1552-6569.2011.00589.x","volume":"22","author":"AB Cohen","year":"2012","unstructured":"Cohen AB, Neema M, Arora A, Dell'Oglio E, Benedict RH, Tauhid S, Goldberg-Zimring D, Chavarro-Nieto C, Ceccarelli A, Klein JP, Stankiewicz JM, Houtchens MK, Buckle GJ, Alsop DC, Guttmann CR, Bakshi R: The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis. J Neuroimaging. 2012, 22 (2): 122-128. 10.1111\/j.1552-6569.2011.00589.x.","journal-title":"J Neuroimaging"},{"issue":"2","key":"246_CR10","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1148\/radiol.13122566","volume":"269","author":"C Lukas","year":"2013","unstructured":"Lukas C, Sombekke MH, Bellenberg B, Hahn HK, Popescu V, Bendfeldt K, Radue EW, Gass A, Borgwardt SJ, Kappos L, Naegelin Y, Knol DL, Polman CH, Geurts JJG, Barkhof F, Vrenken H, Lukas C: Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients. Radiology. 2013, 269 (2): 542-552. 10.1148\/radiol.13122566.","journal-title":"Radiology"},{"issue":"4","key":"246_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neurad.2008.12.008","volume":"36","author":"C Cassinotto","year":"2009","unstructured":"Cassinotto C, Deramond H, Olindo S, Aveillan M, Smadja D, Cabre P: MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis. J Neuroradiol. 2009, 36 (4): 199-205. 10.1016\/j.neurad.2008.12.008.","journal-title":"J Neuroradiol"},{"key":"246_CR12","doi-asserted-by":"crossref","unstructured":"Yonezu T, Ito S, Mori M, Ogawa Y, Makino T, Uzawa A, Kuwabara S: \"Bright spotty lesions\" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis. Mult Scler 2013.,","DOI":"10.1177\/1352458513495581"},{"issue":"12","key":"246_CR13","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1136\/jnnp-2011-300403","volume":"82","author":"A Nagaishi","year":"2011","unstructured":"Nagaishi A, Takagi M, Umemura A, Tanaka M, Kitagawa Y, Matsui M, Nishizawa M, Sakimura K, Tanaka K: Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes. J Neurol Neurosurg Psychiatry. 2011, 82 (12): 1360-1364. 10.1136\/jnnp-2011-300403.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"246_CR14","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG: Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006, 66 (10): 1485-1489. 10.1212\/01.wnl.0000216139.44259.74.","journal-title":"Neurology"},{"issue":"3","key":"246_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3988\/jcn.2011.7.3.115","volume":"7","author":"W Kim","year":"2011","unstructured":"Kim W, Kim SH, Kim HJ: New insights into neuromyelitis optica. J Clin Neurol. 2011, 7 (3): 115-127. 10.3988\/jcn.2011.7.3.115.","journal-title":"J Clin Neurol"},{"issue":"6","key":"246_CR16","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1191\/1352458505ms1203oa","volume":"11","author":"RA Rudick","year":"2005","unstructured":"Rudick RA, Cutter GR, Baier M, Weinstock-Guttman B, Mass MK, Fisher E, Miller DM, Sandrock AW: Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients. Mult Scler. 2005, 11 (6): 626-634. 10.1191\/1352458505ms1203oa.","journal-title":"Mult Scler"},{"issue":"8","key":"246_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.clineuro.2011.04.013","volume":"113","author":"KH Chan","year":"2011","unstructured":"Chan KH, Tsang KL, Ho PW, Tse CT, Kwan JS, Ho JW, Chu AC, Chang RS, Ho SL: Clinical outcome of relapsing remitting multiple sclerosis among Hong Kong Chinese. Clin Neurol Neurosurg. 2011, 113 (8): 617-622. 10.1016\/j.clineuro.2011.04.013.","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"246_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1191\/1352458505ms1207oa","volume":"11","author":"M Pinholt","year":"2005","unstructured":"Pinholt M, Frederiksen JL, Andersen PS, Christiansen M: Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis. Mult Scler. 2005, 11 (5): 511-515. 10.1191\/1352458505ms1207oa.","journal-title":"Mult Scler"},{"issue":"5","key":"246_CR19","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1007\/s00415-012-6809-7","volume":"260","author":"L Kappos","year":"2013","unstructured":"Kappos L, O'Connor PW, Polman CH, Vermersch P, Wiendl H, Pace A, Zhang A, Hotermans C: Clinical effects of natalizumab on multiple sclerosis appear early in treatment course. J Neurol. 2013, 260 (5): 1388-1395. 10.1007\/s00415-012-6809-7.","journal-title":"J Neurol"},{"issue":"1\u20132","key":"246_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jns.2008.12.029","volume":"279","author":"S Siritho","year":"2009","unstructured":"Siritho S, Freedman MS: The prognostic significance of cerebrospinal fluid in multiple sclerosis. J Neurol Sci. 2009, 279 (1\u20132): 21-25. 10.1016\/j.jns.2008.12.029.","journal-title":"J Neurol Sci"},{"issue":"3","key":"246_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/archneur.63.3.390","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG: Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006, 63 (3): 390-396. 10.1001\/archneur.63.3.390.","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"246_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jns.2010.12.001","volume":"302","author":"JE Kim","year":"2011","unstructured":"Kim JE, Kim SM, Ahn SW, Lim BC, Chae JH, Hong YH, Park KS, Sung JJ, Lee KW: Brain abnormalities in neuromyelitis optica. J Neurol Sci. 2011, 302 (1\u20132): 43-48. 10.1016\/j.jns.2010.12.001.","journal-title":"J Neurol Sci"},{"issue":"3","key":"246_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ana.21753","volume":"66","author":"S Ito","year":"2009","unstructured":"Ito S, Mori M, Makino T, Hayakawa S, Kuwabara S: \"Cloud-like enhancement\" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol. 2009, 66 (3): 425-428. 10.1002\/ana.21753.","journal-title":"Ann Neurol"},{"issue":"2","key":"246_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1212\/WNL.38.2.180","volume":"38","author":"DW Paty","year":"1988","unstructured":"Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA, Eisen KA, Purves SJ, Low MD, Brandejs V: MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1988, 38 (2): 180-185. 10.1212\/WNL.38.2.180.","journal-title":"Neurology"},{"issue":"5","key":"246_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/jnnp-2012-304039","volume":"84","author":"A Uzawa","year":"2013","unstructured":"Uzawa A, Mori M, Masuda S, Muto M, Kuwabara S: CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica. J Neurol Neurosurg Psychiatry. 2013, 84 (5): 517-522. 10.1136\/jnnp-2012-304039.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"246_CR26","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1177\/1352458512457845","volume":"19","author":"H Wang","year":"2013","unstructured":"Wang H, Wang K, Wang C, Zhong X, Qiu W, Hu X: Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica. Mult Scler. 2013, 19 (7): 926-931. 10.1177\/1352458512457845.","journal-title":"Mult Scler"},{"issue":"4","key":"246_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jocn.2007.02.090","volume":"15","author":"FB Aksungar","year":"2008","unstructured":"Aksungar FB, Topkaya AE, Yildiz Z, Sahin S, Turk U: Coagulation status and biochemical and inflammatory markers in multiple sclerosis. J Clin Neurosci. 2008, 15 (4): 393-397. 10.1016\/j.jocn.2007.02.090.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"246_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bbrc.2012.08.045","volume":"426","author":"RD Wight","year":"2012","unstructured":"Wight RD, Tull CA, Deel MW, Stroope BL, Eubanks AG, Chavis JA, Drew PD, Hensley LL: Resveratrol effects on astrocyte function: relevance to neurodegenerative diseases. Biochem Biophys Res Commun. 2012, 426 (1): 112-115. 10.1016\/j.bbrc.2012.08.045.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"246_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12288-011-0087-x","volume":"28","author":"GM Hon","year":"2012","unstructured":"Hon GM, Hassan MS, van Rensburg SJ, Abel S, Erasmus RT, Matsha T: Peripheral blood mononuclear cell membrane fluidity and disease outcome in patients with multiple sclerosis. Indian J Hematol Blood Transfus. 2012, 28 (1): 1-6. 10.1007\/s12288-011-0087-x.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"7","key":"246_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1177\/1352458508091368","volume":"14","author":"J Sellner","year":"2008","unstructured":"Sellner J, Greeve I, Mattle HP: Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosis. Mult Scler. 2008, 14 (7): 981-984. 10.1177\/1352458508091368.","journal-title":"Mult Scler"},{"key":"246_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2377-13-72","volume":"13","author":"C Cheng","year":"2013","unstructured":"Cheng C, Jiang Y, Chen X, Dai Y, Kang Z, Lu Z, Peng F, Hu X: Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions. BMC Neurol. 2013, 13: 72-10.1186\/1471-2377-13-72.","journal-title":"BMC Neurol"},{"key":"246_CR32","doi-asserted-by":"crossref","unstructured":"Wang H, Wang K, Wang C, Qiu W, Lu Z, Hu X: Elevated soluble C5b-9 in CSF of neuromyelitis optica. Scand J Immunol 2013.,","DOI":"10.1111\/sji.12132"},{"issue":"1\u20132","key":"246_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jneuroim.2012.09.002","volume":"254","author":"H Kuroda","year":"2013","unstructured":"Kuroda H, Fujihara K, Takano R, Takai Y, Takahashi T, Misu T, Nakashima I, Sato S, Itoyama Y, Aoki M: Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica. J Neuroimmunol. 2013, 254 (1\u20132): 178-182. 10.1016\/j.jneuroim.2012.09.002.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"246_CR34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1177\/1352458508099139","volume":"15","author":"H Doi","year":"2009","unstructured":"Doi H, Matsushita T, Isobe N, Matsuoka T, Minohara M, Ochi H, Kira JI: Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody. Mult Scler. 2009, 15 (3): 304-310. 10.1177\/1352458508099139.","journal-title":"Mult Scler"},{"issue":"20","key":"246_CR35","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1212\/WNL.0b013e3181c1deb9","volume":"73","author":"K Yanagawa","year":"2009","unstructured":"Yanagawa K, Kawachi I, Toyoshima Y, Yokoseki A, Arakawa M, Hasegawa A, Ito T, Kojima N, Koike R, Tanaka K, Kosaka T, Tan CF, Kakita A, Okamoto K, Tsujita M, Sakimura K, Takahashi H, Nishizawa M: Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis. Neurology. 2009, 73 (20): 1628-1637. 10.1212\/WNL.0b013e3181c1deb9.","journal-title":"Neurology"},{"issue":"9","key":"246_CR36","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1177\/1352458512436593","volume":"18","author":"EC Klawiter","year":"2012","unstructured":"Klawiter EC, Xu J, Naismith RT, Benzinger TL, Shimony JS, Lancia S, Snyder AZ, Trinkaus K, Song SK, Cross AH: Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis. Mult Scler. 2012, 18 (9): 1259-1268. 10.1177\/1352458512436593.","journal-title":"Mult Scler"},{"issue":"11","key":"246_CR37","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1212\/01.wnl.0000256820.26489.17","volume":"68","author":"I Miyazawa","year":"2007","unstructured":"Miyazawa I, Nakashima I, Petzold A, Fujihara K, Sato S, Itoyama Y: High CSF neurofilament heavy chain levels in neuromyelitis optica. Neurology. 2007, 68 (11): 865-867. 10.1212\/01.wnl.0000256820.26489.17.","journal-title":"Neurology"},{"issue":"11","key":"246_CR38","first-page":"852","volume":"47","author":"K Tanaka","year":"2007","unstructured":"Tanaka K: Anti-aquaporin 4 antibody in Japanese multiple sclerosis with long spinal cord lesions. Rinsho Shinkeigaku. 2007, 47 (11): 852-854.","journal-title":"Rinsho Shinkeigaku"},{"issue":"2","key":"246_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00401-010-0704-z","volume":"120","author":"R Sharma","year":"2010","unstructured":"Sharma R, Fischer MT, Bauer J, Felts PA, Smith KJ, Misu T, Fujihara K, Bradl M, Lassmann H: Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination. Acta Neuropathol. 2010, 120 (2): 223-236. 10.1007\/s00401-010-0704-z.","journal-title":"Acta Neuropathol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-014-0246-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-014-0246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-014-0246-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-014-0246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:18:22Z","timestamp":1630567102000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-014-0246-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["246"],"URL":"https:\/\/doi.org\/10.1186\/s12883-014-0246-4","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"19 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"246"}}